HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of acromegaly in Aarhus University Hospital. A retrospective investigation of the period from 1994 to 2004].

AbstractINTRODUCTION:
Traditional treatment of acromegaly comprises surgery and somatostatin analogs (SA), which however is effective in no more than 80%. New treatments are available which prompted us to follow up our results of surgery and/or SA.
PATIENTS AND METHODS:
In a retrospective design we followed all 41 patients with newly diagnosed acromegaly at Aarhus University Hospital from 1994 to 2004. 35 patients underwent surgery of whom 10 also received SA. Six patients only received SA. The criteria for cure was a nadir GH level < 0.5 mg/l and/or normalisation of serum IGF-I.
RESULTS:
The overall cure rate after surgery was 56%. A cure rate of 89% was observed if the tumor size was < 10 mm in maximal diameter. In the surgery-only group serum IGF-I continued to decline when comparing the first and last postoperative levels. Treatment with SA was effective in 40% and a sufficient response with SA as monotherapy was observed in 67%. Serum IGF-I levels were lower in female as compared to male patients both before and after treatment.
CONCLUSIONS:
1) The treatment outcome of acromegaly in this population is comparable to international standards. 2) The continuous decline in IGF-I levels as a function of time after surgery, and the gender difference in IGF-I levels must be accounted for when evaluating individual patients. 3) an insufficient response to conventional therapy was observed in 25% of the cases, which is a result that justifies development of new treatment modalities.
AuthorsMichael Madsen, Esben Boll Matthiesen, Per Løgstrup Poulsen, Jørgen Weeke, Jens Astrup, Jens Otto Lunde Jørgensen
JournalUgeskrift for laeger (Ugeskr Laeger) Vol. 169 Issue 10 Pg. 907-10 (Mar 05 2007) ISSN: 1603-6824 [Electronic] Denmark
Vernacular TitleBehandling af akromegali på Arhus Universitetshospital. En retrospektiv opgørelse fra perioden 1994-2004.
PMID17359734 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Somatostatin
  • Insulin-Like Growth Factor I
Topics
  • Acromegaly (drug therapy, surgery, therapy)
  • Adenoma (drug therapy, surgery)
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Growth Hormone-Secreting Pituitary Adenoma (drug therapy, surgery)
  • Humans
  • Insulin-Like Growth Factor I (analysis)
  • Male
  • Middle Aged
  • Pituitary Neoplasms (drug therapy, surgery)
  • Retrospective Studies
  • Somatostatin (analogs & derivatives, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: